BioCentury
ARTICLE | Distillery Therapeutics

Cancer

October 31, 2018 8:22 PM UTC

Cell culture and mouse studies suggest inhibiting KDM4B alone or in combination with PI3K could help treat PTEN-deficient triple-negative breast cancer (TNBC). In a PTEN-deficient TNBC cell line, two ...